Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

Schols, A. M.; Buurman, W. A.; Staal van den Brekel, A. J.; Dentener, M. A.; Wouters, E. F.
August 1996
Thorax;Aug1996, Vol. 51 Issue 8, p819
Academic Journal
No abstract available.


Related Articles

  • Kronik Obstr�ktif Akciger Hastaliginin Sistemik Etkileri. BOZBAs, serife SAVAs; ULUBAY, Gaye // Akciger Arsivi/Archives of Lung;2010, Vol. 11 Issue 2, p47 

    Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation in the lungs. Chronic obstruction to airflow is seen due to structural changes in lung parenchyma and airways. These structural changes observed in COPD are related to inflammation in the airways, alveoli and...

  • Adiponectin: An Attractive Marker for Metabolic Disorders in Chronic Obstructive Pulmonary Disease (COPD). Bianco, Andrea; Mazzarella, Gennaro; Turchiarelli, Viviana; Nigro, Ersilia; Corbi, Graziamaria; Scudiero, Olga; Sofia, Matteo; Daniele, Aurora // Nutrients;Oct2013, Vol. 5 Issue 10, p4115 

    Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease which may be complicated by development of co-morbidities including metabolic disorders. Metabolic disorders commonly associated with this disease contribute to lung function impairment and mortality. Systemic...

  • Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives. Tkacova, Ruzena // Mediators of Inflammation;2010, Vol. 2010, p1 

    Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Low-grade systemic inflammation is considered a hallmark of COPD that potentially links COPD to increased rate of systemic manifestations of the disease. Obesity with/without the metabolic...

  • Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease. Skyba, Peter; Ukropec, Jozef; Pobeha, Pavol; Ukropcova, Barbara; Joppa, Pavol; Kurdiova, Timea; Stroffekova, Katarina; Brusik, Miroslav; Klimes, Iwar; Tkac, Ivan; Gasperikova, Daniela; Tkacova, Ruzena // Mediators of Inflammation;2010, Vol. 2010, p1 

    Potential links between metabolic derangements and adipose tissue (AT) inflammation in patients with chronic obstructive pulmonary disease (COPD) are unexplored. We investigated AT expressions of interleukin (IL)-6, tumor necrosis factor (TNF)-α, CD68 (macrophage cell surface receptor),...

  • Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. Kythreotis, Prokopis; Kokkini, Ageliki; Avgeropoulou, Stavrina; Hadjioannou, Argyro; Anastasakou, Efgenia; Rasidakis, Antonis; Bakakos, Petros // BMC Pulmonary Medicine;2009, Vol. 9, Special section p1 

    Background: Recent studies have provided evidence for a link between leptin and tumor necrosis factor-alpha (TNF-α). Insulin-like growth factor I (IGF-I) mediates the metabolic effects of growth hormone (GH). The GH axis is believed to be suppressed in chronic obstructive pulmonary disease...

  • Metabolic Derangements in Lichen Planus - A Case Control Study. KAR, BIKASH RANJAN; PANDA, MAITREYEE; PATRO, NIBEDITA // Journal of Clinical & Diagnostic Research;Nov2016, Vol. 10 Issue 11, p1 

    Introduction: An association between psoriasis and metabolic syndrome has been established in previous studies. Lichen Planus (LP) is also a chronic inflammatory disease morphologically related to psoriasis and few studies have shown association of metabolic derangements in LP. Aim: To study the...

  • Systemic inflammation, depression and obstructive pulmonary function: a population-based study. Yanxia Lu; Lei Feng; Liang Feng; Ma Shwe Nyunt; Keng Bee Yap; Tze Pin Ng // Respiratory Research;May2013, Vol. 14 Issue 5, p1 

    Background: Levels of Interleukin-6 (IL-6) and C-creative protein (CRP) indicating systemic inflammation are known to be elevated in chronic diseases including chronic obstructive pulmonary disease (COPD) and depression. Comorbid depression is common in patients with COPD, but no studies have...

  • Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Liang Dong; Jing-wen Xia; Yi Gong; Zhen Chen; Hai-hua Yang; Jing Zhang; Jian He; Xiao-dong Chen // Evidence-based Complementary & Alternative Medicine (eCAM);2014, Vol. 2014, p1 

    Chronic obstructive pulmonary disease (COPD) is characterized by a chronic inflammatory response that is worsened by acute exacerbations. Lianhuaqingwen (LHQW) has anti-inflammatory and immune regulatory functions and may inhibit the airway inflammation that occurs during an acute exacerbation...

  • Nonpharmacologic adjuncts to training during pulmonary rehabilitation: The role of supplemental oxygen and noninvasive ventilation. Guy W. Soo Hoo, Carolyn L. // Journal of Rehabilitation Research & Development;Sep/Oct2003 Supplement 2, Vol. 40 Issue 5, p81 

    Exercise training is the cornerstone of pulmonary rehabilitation. However, patients may not be able to exercise at a level that produces a training effect because of limitations related to their underlying lung disease. Adjuncts during exercise training may increase their exercise capacity and...

  • Genetic and Environmental Determinants of Chronic Obstructive Pulmonary Disease. Larson, Roger K.; Barman, Martin L.; Keuppers, Friedrich; Fudenberg, Hugh // Annals of Internal Medicine;May70, Vol. 72 Issue 5, p627 

    The prevalence of abnormalities of pulmonary function among 156 relatives of 61 patients with chronic obstructive pulmonary disease was found to be significantly higher than the prevalence in a control group of their spouses. No relationship of this increased familial prevalence to...


Read the Article


Sign out of this library

Other Topics